Medroxyprogesterone 10 mg
Pro Research Analysisby 
Searched over 200M research papers
Medroxyprogesterone 10 mg: Efficacy, Safety, and Clinical Applications
Introduction to Medroxyprogesterone 10 mg
Medroxyprogesterone acetate (MPA) is a synthetic progestin commonly used in various clinical settings, including contraception, hormone replacement therapy, and the treatment of certain cancers. This article synthesizes recent research on the efficacy, safety, and clinical applications of MPA, particularly focusing on the 10 mg oral dosage.
Efficacy in Oocyte Donation
Ovarian Response and Reproductive Outcomes
A randomized controlled trial compared the use of 10 mg MPA with a gonadotropin-releasing hormone (GnRH) antagonist in oocyte donors. The study found that the number of oocytes retrieved, endocrine profiles, and pregnancy outcomes were similar between the two groups. Specifically, the MPA group had an average of 21.4 oocytes retrieved compared to 21.2 in the antagonist group, with no significant differences in implantation, clinical pregnancy, or live birth rates . This suggests that MPA is an effective alternative to GnRH antagonists for ovarian stimulation in oocyte donation.
Pharmacokinetics and Ovulation Suppression
Plasma Concentration and Hormonal Effects
Research on the plasma concentration of MPA after oral administration of 10 mg daily showed rapid absorption, with peak levels occurring within 1-3 hours. The study indicated that 10 mg MPA effectively inhibits ovulation, as evidenced by the lack of progesterone increase during the treatment period . This dosage is sufficient to suppress ovulation, making it a reliable option for contraception.
Safety and Side Effects
Elemental Impurities and Method Validation
A study on the analytical method development for MPA tablets (10 mg) using inductively coupled plasma mass spectrometry (ICP-MS) confirmed the method's precision, accuracy, and reliability in detecting elemental impurities such as cadmium, lead, arsenic, mercury, and lithium . This ensures the safety and quality of MPA tablets for clinical use.
Comparison with Other Hormonal Treatments
In a comparative study of MPA with other hormonal treatments for advanced prostatic cancer, MPA was found to have a less favorable course in terms of survival and time to progression compared to diethylstilbestrol and cyproterone acetate. However, the cardiovascular side effects were relatively low, indicating a manageable safety profile .
Clinical Applications
Hormone Replacement Therapy
A bioavailability study in menopausal women compared different hormone replacement therapy (HRT) drugs containing MPA. The study found no significant differences in estradiol levels between the drugs, although MPA concentrations varied. This suggests that MPA can be effectively used in HRT formulations .
Contraceptive Efficacy
Depot formulations of MPA, such as the subcutaneous injection (104 mg/0.65 mL), have been shown to effectively suppress ovulation for at least 91 days in various populations, including Asian women. The pharmacokinetic profiles were consistent across different ethnicities and injection sites, supporting the broad applicability of MPA in contraceptive use .
Conclusion
Medroxyprogesterone acetate 10 mg is a versatile and effective medication for various clinical applications, including oocyte donation, contraception, and hormone replacement therapy. Its efficacy in suppressing ovulation and favorable safety profile make it a valuable option in reproductive medicine. Further research and method validation continue to support its use in diverse patient populations.
Sources and full results
Most relevant research papers on this topic